exercise-induced malignant hyperthermia
ORPHA: 466650
Overview
human disease
Available Treatments (0)
No treatments linked yet
Clinical trials or compassionate use may be available — consult a specialist.
Clinical Presentation
Signs and symptoms associated with exercise-induced malignant hyperthermia, sourced from HPO and Orphanet clinical annotations.
Abnormality of the nervous systemMalignant hyperthermiaNauseaHeadacheVertigoTachypneaSinus tachycardiaFatigueAbnormal pulse pressureSeizureAtaxiaLethargyConfusionMuscle weaknessDecreased liver functionProlonged QT intervalAbnormal bleedingVomitingHyperkalemiaHypotensionHypocalcemiaHyperphosphatemiaLactic acidosisElevated circulating creatine kinase concentrationAbnormality of the coagulation cascadeExercise-induced muscle crampsAbnormal T-waveST segment depressionHypocapniaCracklesDeliriumFlushingOliguriaDry skinAnhidrosisHepatic failureThrombocytopeniaAcute kidney injuryHepatic encephalopathyRhabdomyolysisDisseminated intravascular coagulation
Classification & Codes
Orphanet Code
ORPHA:466650exercise-induced malignant hyperthermia
| Orphanet | ORPHA:466650 |
| Treatments | 0 drug(s) |
| Symptoms on record | 41 signs |
| Status | published |
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO